Author:
Shimatani Takuro,Hosotani Nobuo,Ohnishi Masako,Kumagai Kazuo,Saji Ikutaro
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference14 articles.
1. Wang Z, Walter M, Selwood T, Rubin H, Schechter NM . Recombinant expression of human mast cell proteases chymase and tryptase. Biol Chem 379: 167–174 ( 1998)
2. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A . Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348–22357 ( 1990)
3. Sukenaga Y, Kamoshita K, Takai S, Miyazaki M . Development and application of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities. Jpn J Pharmacol 90: 218–222 ( 2002)
4. Lee M, von Eckardstein A, Lindstedt L, Assmann G, Kovanen PT . Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macropharge foam cells induced by plasma. Arterioscler Thromb Vasc Biol 19: 1066–1074 ( 1999)
5. He S, Gaca MD, McEuen AR, Walls AF . Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 291: 517–523 ( 1999)
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献